These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14666997)

  • 1. Comparison of prostate gene expression and tissue weight changes as monitors of antiandrogen activity in GNRH-inhibited rats.
    Nellemann C; Lefevre PA; Ashby J
    Birth Defects Res B Dev Reprod Toxicol; 2003 Aug; 68(4):344-54. PubMed ID: 14666997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism.
    Kelce WR; Lambright CR; Gray LE; Roberts KP
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):192-200. PubMed ID: 9007049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement of surgical castration by GnRH-inhibition or Leydig cell ablation in the male rat Hershberger antiandrogen assay.
    Ashby J; Lefevre PA; Deghenghi R; Wallis N
    Regul Toxicol Pharmacol; 2001 Oct; 34(2):188-203. PubMed ID: 11603962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of antiandrogen effect determined by Lightcycler technology.
    Nellemann C; Vinggaard AM; Dalgaard M; Hossaini A; Larsen JJ
    Toxicology; 2001 May; 163(1):29-38. PubMed ID: 11376863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiandrogenic effects in short-term in vivo studies of the fungicide fenarimol.
    Vinggaard AM; Jacobsen H; Metzdorff SB; Andersen HR; Nellemann C
    Toxicology; 2005 Feb; 207(1):21-34. PubMed ID: 15590119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action and pure antiandrogenic properties of flutamide.
    Labrie F
    Cancer; 1993 Dec; 72(12 Suppl):3816-27. PubMed ID: 8252497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA.
    Martel C; Trudel C; Couet J; Labrie C; Bélanger A; Labrie F
    Mol Cell Endocrinol; 1993 Feb; 91(1-2):43-9. PubMed ID: 8472853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the rodent Hershberger bioassay: testing of coded chemicals and supplementary molecular-biological and biochemical investigations.
    Freyberger A; Ellinger-Ziegelbauer H; Krötlinger F
    Toxicology; 2007 Sep; 239(1-2):77-88. PubMed ID: 17688994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the antiandrogenic effects of flutamide, DDE, and linuron in the weanling rat assay using organ weight, histopathological, and proteomic approaches.
    Tinwell H; Friry-Santini C; Rouquié D; Belluco S; Elies L; Pallen C; Bars R
    Toxicol Sci; 2007 Nov; 100(1):54-65. PubMed ID: 17686919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of anti-androgenic activity of flutamide, vinclozolin, procymidone, linuron, and p, p'-DDE in rodent 10-day Hershberger assay.
    Kang IH; Kim HS; Shin JH; Kim TS; Moon HJ; Kim IY; Choi KS; Kil KS; Park YI; Dong MS; Han SY
    Toxicology; 2004 Jul; 199(2-3):145-59. PubMed ID: 15147789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In utero exposure to antiandrogens alters the responsiveness of the prostate to p,p'-DDE in adult rats and may induce prostatic inflammation.
    You L; Brenneman KA; Heck H
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):258-66. PubMed ID: 10620483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a 15-day screening assay using intact male rats for identifying antiandrogens.
    O'Connor JC; Frame SR; Ladics GS
    Toxicol Sci; 2002 Sep; 69(1):92-108. PubMed ID: 12215663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined effects of vinclozolin and procymidone do not deviate from expected additivity in vitro and in vivo.
    Nellemann C; Dalgaard M; Lam HR; Vinggaard AM
    Toxicol Sci; 2003 Feb; 71(2):251-62. PubMed ID: 12563111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the environmental antiandrogen p,p-DDE in CD and long-evans rats using a tier I screening battery and a Hershberger assay.
    O'Connor JC; Frame SR; Davis LG; Cook JC
    Toxicol Sci; 1999 Sep; 51(1):44-53. PubMed ID: 10496676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate.
    Rittmaster RS; Magor KE; Manning AP; Norman RW; Lazier CB
    Mol Endocrinol; 1991 Jul; 5(7):1023-9. PubMed ID: 1719382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissection and weighing of accessory sex glands after formalin fixation, and a 5-day assay using young mature rats are reliable and feasible in the Hershberger assay.
    Yamada T; Sunami O; Kunimatsu T; Kamita Y; Okuno Y; Seki T; Nakatsuka I; Matsuo M
    Toxicology; 2001 May; 162(2):103-19. PubMed ID: 11337110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of an antiandrogen and a 5 alpha-reductase inhibitor: a further step towards total androgen blockade?
    Labrie C; Trudel C; Li S; Martel C; Couêt J; Labrie F
    Endocrinology; 1991 Jul; 129(1):566-8. PubMed ID: 2055205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of gene expression by androgen and oestrogens in the testis and prostate of the adult rat following androgen withdrawal.
    Turner KJ; Morley M; MacPherson S; Millar MR; Wilson JA; Sharpe RM; Saunders PT
    Mol Cell Endocrinol; 2001 Jun; 178(1-2):73-87. PubMed ID: 11403897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OECD validation of phase-3 Hershberger assay using the stimulated weanling male rat in Korea.
    Moon HJ; Kang TS; Kim TS; Kang IH; Kim SH; Han SY
    J Appl Toxicol; 2010 May; 30(4):361-8. PubMed ID: 20082360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a 5-day Hershberger assay using young mature male rats: methyltestosterone and p,p'-DDE, but not fenitrothion, exhibited androgenic or antiandrogenic activity in vivo.
    Sunami O; Kunimatsu T; Yamada T; Yabushita S; Sukata T; Miyata K; Kamita Y; Okuno Y; Seki T; Nakatsuka I; Matsuo M
    J Toxicol Sci; 2000 Dec; 25(5):403-15. PubMed ID: 11201171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.